Reaction

Catheter Site Discharge reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,086 reports · 26 co-occurring drugs

As of the last recalculation, Catheter Site Discharge appears in 1,086 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 612.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Epoprostenol302612.1626.6
Macitentan21473.573.7
Sildenafil16865.665.8
Treprostinil30664.764.8
Sildenafil Powder,9958.658.7
Tadalafil23657.457.6
Sildenafil Citrate26552.552.6
Riociguat7245.345.4
Ambrisentan20438.338.4
Bosentan8836.336.4
0Xygen8636.336.3
Oxygen8636.336.3
Selexipag3728.428.4
Bumetanide3022.422.4
Teduglutide1521.621.6
Metolazone1220.720.7
Sodium Chloride Tablet5214.214.2
Sodium Chloride Tablets5214.214.2
Warfarin8413.713.7
Sodium Chloride5213.213.2
Hydroxyzine Hydrochloride811.711.7
Hydroxyzine Hydrochloride Oral811.711.7
Rasagiline Mesylate610.410.4
Amantadine810.010.0
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose37.07.0
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride106.26.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.